Manish Sadarangani, BM BCh, FRCPC, DPhil

University of British Columbia, Canada

Poster(s):

• (1158) Immunogenicity of COVID-19 vaccine four-dose series in healthy community dwelling adults 50 years and above: interim analysis from the ‘PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines’ (PREVENT-COVID) study
  Friday, October 13, 2023

  12:15 PM – 1:30 PM US ET

• (1165) Longitudinal Evaluation of SARS-CoV-2 Antibody Response Using Dried Blood Spot Samples Following Vaccination with Three and Four Doses of mRNA-1273, BNT162b2 and/or ChAdOx1-S in Adults Aged 50 and Above: Interim Analysis from the PREVENT-COVID Study
  Friday, October 13, 2023

  12:15 PM – 1:30 PM US ET

• (1325) Neurodevelopmental outcomes in preschoolers following viral meningitis is Canterbury, New Zealand
  Friday, October 13, 2023

  12:15 PM – 1:30 PM US ET

• (1726) Characterization of humoral immune responses to COVID-19 vaccination in children in Canada: interim analysis from the Severe acute respiratory syndrome-related coronavirus 2 PRevalence In children and youNG adults in British Columbia (SPRING) Study
  Friday, October 13, 2023

  12:15 PM – 1:30 PM US ET

• (2596) Title: The Dynamics Of Invasive Pneumococcal Disease (IPD) due to Streptococcus pneumoniae and Impact Of Pneumococcal Conjugate Vaccines (PCVs) In Canada From 2000-2019
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET

• (2613) Pediatric respiratory syncytial virus hospitalizations, 2017 to 2022, the Canadian Immunization Monitoring Program Active (IMPACT)
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET